US-approved vaccines effective against B.1.617 variant of Covid-19: Official
PTI, May 13, 2021, 9:40 AM IST
Image Credit: Pixaby
Washington: Covid-19 vaccines approved by the United States like Pfizer, Moderna and Johnson and Johnson have effectiveness against the B.1.617 variant of the virus that is predominant in India, which is experiencing one of the worst outbreaks of the pandemic, a top American health official said.
The observation is based on the latest data about the variant and the three major vaccines approved by the United States, said Dr Francis Collins, Director of National Institute of Science.
“The data is coming in, and it looks very encouraging that the US-approved vaccines, the Pfizer, the Moderna, the J&J, do have effectiveness against this variant called B.1.617,” Collins told the media.
“It’s a little less effective in that case than some of the others, but it looks like it ought to be good enough to make Americans protected. And that’s really a good thing to hear,” he said in response to a question.
Early this week, the World Health Organization classified the B.1.617 SARS-CoV-2 variant, which was first detected in India, as a variant of concern. The WHO said that evidence showed B.1.617 was more transmissible.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Covid-19: Serum Institute to begin Novavax Covid 19 vaccine trials for children in July
Rafael Nadal says he will not play at Wimbledon or Tokyo Olympics
Fortis Healthcare says COVID vaccines protected 92% vaccinated healthcare workers
Related Articles More
Delta variant infections doubling every 11 days in England, study finds
Anti-inflammation drug may effectively treat COVID-19 complications in children: Study
Which COVID vaccine is best? Here’s why that’s really hard to answer
US CDC classifies Delta variant as ”variant of concern”
A fifth of asymptomatic covid patients develop ‘Long Covid’: study
Mangaluru: Three booked for trying to extort money posing as MCC officials; One arrested
International debate on ”vaccine passports” must focus on ”vaccine equity”: India
Xiaomi, Apple, Samsung among most popular brands in pre-owned smartphone market: Report
Household heating, cooking behind 40 pc of Delhi’s PM 2.5 pollution last Dec, Jan: Study
CureVac: Vaccine data are ”sobering” full results in weeks